TEGAN HADLEY: Open Payments
NPI 1275050718 · SURF CITY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$252 in 14 payments from 10 companies in 2025. Trend: 2023 $117 · 2024 $70 · 2025 $252
Food & beverage: $252
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Novo Nordisk Inc | 2 | $35 |
| Vanda Pharmaceuticals Inc. | 2 | $31 |
| Exeltis, USA Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $21 |
| Bausch Health US, LLC | 1 | $17 |
| Amgen Inc. | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Phadia US Inc. | 1 | $16 |
Products named: HETLIOZ, BREZTRI, SLYND, QULIPTA, AIRSUPRA, Wegovy, Rybelsus, APLENZIN.
Industry payments across NC — which companies pay providers there.
